Report Summary
China's demand for Hepatitis Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

I. INTRODUCTION
    Report Scope and Methodology
    Executive Summary
II. BUSINESS ENVIRONMENT
    Economic Outlook
    Key Economic Indicators
    Industrial Output
    Population and Labor
    Foreign Investment
    Foreign Trade
    Financial and Tax Regulations
    Banking System and Regulations
    Foreign Exchange
    Taxes, Tariff and Custom Duties
III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
    Hepatitis Drugs Industry Structure
    Market Size
    Market Growth Drivers
    Hepatitis Drugs Industry Sales Volumes
    Major Producer Facility Locations and Sales Volumes
    Market Share of Key Producers
    Labor Cost
    Potential Entrants
    Major Distributors
    Major Foreign Investment
    Technology Development
IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
    Overview
    Sales Volumes of Hepatitis Drugs by Region in 2008
    Hepatitis Drugs Sales Volumes
    Liver Protection Drugs
    Nucleoside Drugs
    Interferon (IFN)
    Other Hepatitis Drugs
    Hepatitis Drugs Imports and Exports
    Hepatitis Drugs Imports
    Hepatitis Drugs Exports
    Pricing Trend
V. HEPATITIS DRUGS MARKET OUTLOOK
    Hepatitis Drugs Market Outlook Overview
    Government Regulation
    Health Care Insurance Industry Overview
    Consumer Spending Trends
    Demographic Trends
    Health Care Industry Trends
    Hospitals and Hospital Beds
    Physicians and Physician Visits
VI. MARKETING STRATEGIES
    China Market Entry Overview
    China’s Distribution System
    Hepatitis Drugs Distribution Channels
    Transportation and Freight Infrastructure
    Communications
    China’s Market Entry
    Export to China
    Indirect export
    Direct Export
    License and Contract Manufacture
    Assembling in China
    Contract Manufacturing
    Trade Permit
    Investment
    Equity Joint Venture
    Contractual Joint Venture
    Wholly Foreign-Owned Enterprise
VII. HEPATITIS DRUGS PRODUCER DIRECTORY
    Hepatitis Drugs Producer Profiles
LIST OF TABLES
I. INTRODUCTION
    Economic Outlook Summary
II. BUSINESS ENVIRONMENT
    Key Economic Indicators
    Industrial Output
    Population and Labor Force Trends
    Foreign Investment and Loans
    Foreign Trade
III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
    Hepatitis Drugs Industry Sales Volumes
    Major Producer Facility Locations
    Major Hepatitis Drugs Producer Sales Volumes
    Market Share of Key Producers
    Major Foreign Investments in China
IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
    Hepatitis Drugs Sales Volumes
    Sales Volumes of Hepatitis Drugs by Region in 2008
    Major Liver Protection Drugs Producer Sales Volumes
    Liver Protection Drugs Sales Volumes
    Major Nucleoside Drugs Producer Sales Volumes
    Nucleoside Drugs Sales Volumes
    Major IFN Drugs Producer Sales Volumes
    Interferon (IFN) Sales Volumes
    Other Hepatitis Drugs Sales Volumes
    China Hepatitis Drugs Imports and Exports
V. HEPATITIS DRUGS MARKET OUTLOOK
    Total hepatitis Drugs Sales Volumes by Market
    Hepatitis Drugs Sales Volumes and Market Share in 2008
    Consumer Spending Trends
    Demographic Trends
    Health Care Industry Trends
    Hospitals and Hospital Beds
    Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
    China’s Hepatitis Drugs Sales Volumes
II. BUSINESS ENVIRONMENT
    China’s GDP and Growth Rate
    Industrial Output by Ownership
    China’s Imports and Exports
III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS
    Hepatitis Drugs Sales Volumes in China
IV. HEPATITIS DRUGS PRODUCTION AND DEMAND
    Total Hepatitis Drugs Sales Volumes
    Total Hepatitis Drugs Imports and Exports
V. HEPATITIS DRUGS MARKET OUTLOOK
    Hepatitis Drugs Sales Volumes by Market in 2008
VI. MARKETING STRATEGIES
    China’s Distribution Channel